Effects of tibolone on the bone strength of OVX rats

GU Bei,YANG Xin,SHANG Min
2007-01-01
Abstract:Objective To evaluate the effect of tibolone treatment on bone parameters in mature ovariectomized (OVX) rats.Methods Six-month-old rats were allotted to one of four groups (n=10). Sham-operated and control OVX groups received vehicle, whereas other groups (all OVX) received tibolone (0.25 mg/kg/d orally) or Valerate Estriol (VE; 0.8 mg/kg/d orally) for 3 months. Then the animals were anesthetized and an autopsy was performed. Their right femurs and the third vertebra were processed to measure BMD, femoral biomechanical properties. Their fourth and the fifth vertebra were processed to analyze bone histomorphometry. Results Treatment with VE prevented ovariectomy-induced bone loss in peripheral (femur) and axial (L_3) skeleton. In the midshaft femur, tibolone and VE prevented loss of bone strength to a similar extent. Tibolone (0.25 mg/kg/d orally), resulted in 30% greater cortical strength of femur (P≤0.05) compared with vehicle-treated OVX rats.Conclusions We conclude that 3 months of low-dose tibolone treatment prevents ovariectomy-induced deterioration of peripheral skeleton and preserves cortical bone strength.
What problem does this paper attempt to address?